Original research papers, review articles, technical reports, and short communications in all aspects of Agriculture, Biology, Physical, Chemical sciences, Social, Applied Sciences and Clinical medicine, etc., can be submitted on the understanding that the work is not previously published or under consideration for publication elsewhere.


Submission of Manuscript


Please submit your article via http://www.futurejournals.org online system or thefuturejournals@gmail.com for the quick evaluation process and after acceptance, the author can move article to any of the other Future journals.

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process.


Instructions for Authors

  • Manuscript Submission Overview
  • Manuscript Preparation
  • Preparing Figures, Schemes and Tables
  • Original Images for Blots and Gels Requirements
  • Supplementary Materials, Data Deposit and Software Source Code
  • Research and Publication Ethics
  • Reviewer Suggestions
  • English Corrections
  • Preprints and Conference Papers
  • Authorship
  • Editorial Independence
  • Conflict of Interests
  • Editorial Procedures and Peer-Review
  • Promoting Equity, Diversity and Inclusiveness Within FUTURE  Journals
  • Resource Identification Initiative

Submission Checklist


  1. Read the Aims & Scopeto gain an overview and assess if your manuscript is suitable for this journal;
  2. Use the Microsoft Word template (Data Descriptor)or Microsoft Word template (types of papers other than Data Descriptor) or LaTeX template to prepare your manuscript;
  3. Make sure that issues about publication ethicsresearch ethicscopyrightauthorshipfigure formatsdataand references format have been appropriately considered;
  4. Ensure that all authors have approved the content of the submitted manuscript.
  5. Authors are encouraged to add a biography(optional) to the submission and post it to SciProfiles.

Manuscript Submission Overview

Types of Publications

Data has no restrictions on the length of manuscripts, provided that the text is concise and comprehensive. Full experimental details must be provided so that the results can be reproduced. Data requires that authors publish all experimental controls and make full datasets available where possible (see the guidelines on Supplementary Materials and references to unpublished data).

Manuscripts submitted to Data should neither be published previously nor be under consideration for publication in another journal. The main article types are as follows:

  • Data Descriptors: containing a description of a dataset, including methods used for collecting or producing the data, where the dataset may be found, and information about its use.
  • Articles: Original research manuscripts. The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. Authors should not unnecessarily divide their work into several related manuscripts, although short Communications of preliminary, but significant, results will be considered. The quality and impact of the study will be considered during peer review.
  • Reviews: These provide concise and precise updates on the latest progress made in a given area of research. Systematic reviews should follow the PRISMA guidelines.
  • Case reports: Case reports present detailed information on the symptoms, signs, diagnosis, treatment (including all types of interventions), and outcomes of an individual patient. Case reports usually describe new or uncommon conditions that serve to enhance medical care or highlight diagnostic approaches.

Submission Process

Manuscripts for Data should be submitted online at www.thefuturejournals.org. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process. The submitting author must ensure that all eligible co-authors have been included in the author list (read the criteria to qualify for authorship) and that they have all read and approved the submitted version of the manuscript. To submit your manuscript, register and log in to the submission website. Once you have registered, click here to go to the submission form for Data. All co-authors can see the manuscript details in the submission system, if they register and log in using the e-mail address provided during manuscript submission.

Accepted File Formats

Authors are encouraged to use the Microsoft Word template or LaTeX template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. The total amount of data for all files must not exceed 120 MB. If this is a problem, please contact the Editorial Office data@FUTURE .com. Accepted file formats are:

  • Microsoft Word: Manuscripts prepared in Microsoft Word must be converted into a single file before submission. When preparing manuscripts in Microsoft Word, we encourage you to use the Data Microsoft Word template file. Please insert your graphics (schemes, figures, etc.) in the main text after the paragraph of its first citation.
  • LaTeX: Manuscripts prepared in LaTeX must be collated into one ZIP folder (including all source files and images, so that the Editorial Office can recompile the submitted PDF). When preparing manuscripts in LaTeX, we encourage you to use the Data LaTeX template files. You can now also use the online application writeLaTeX to submit articles directly to Data. The FUTURE  LaTeX template file should be selected from the writeLaTeX template gallery.
  • Supplementary files: May be any format, but it is recommended that you use common, non-proprietary formats where possible (see below for further details).

Disclaimer: Usage of these templates is exclusively intended for submission to the journal for peer-review, and strictly limited to this purpose and it cannot be used for posting online on preprint servers or other websites.

Free Format Submission

Data now accepts free format submission:

  • We do not have strict formatting requirements, but all manuscripts must contain the required sections: Author Information, Abstract, Keywords, Introduction, Materials & Methods, Results, Conclusions, Figures and Tables with Captions, Funding Information, Author Contributions, Conflict of Interest and other Ethics Statements. Check the Journal Instructions for Authors for more details.
  • Your references may be in any style, provided that you use the consistent formatting throughout. It is essential to include author(s) name(s), journal or book title, article or chapter title (where required), year of publication, volume and issue (where appropriate) and pagination. DOI numbers (Digital Object Identifier) are not mandatory but highly encouraged. The bibliography software package EndNoteZoteroMendeleyReference Manager are recommended.
  • When your manuscript reaches the revision stage, you will be requested to format the manuscript according to the journal guidelines.

Cover Letter

A cover letter must be included with each manuscript submission. It should be concise and explain why the content of the paper is significant, placing the findings in the context of existing work. It should explain why the manuscript fits the scope of the journal.

Any prior submissions of the manuscript to FUTURE  journals must be acknowledged. If this is the case, it is strongly recommended that the previous manuscript ID is provided in the submission system, which will ease your current submission process. The names of proposed and excluded reviewers should be provided in the submission system, not in the cover letter.

All cover letters are required to include the statements:

  • We confirm that neither the manuscript nor any parts of its content are currently under consideration or published in another journal.
  • All authors have approved the manuscript and agree with its submission to (journal name).

Author Biography

Authors are encouraged to add a biography (maximum 150 words) to the submission and post it to SciProfiles. This should be a single paragraph and should contain the following points:

  1. Authors’ full names followed by current positions;
  2. Education background including institution information and year of graduation (type and level of degree received);
  3. Work experience;
  4. Current and previous research interests;
  5. Memberships of professional societies and awards received.

Note for Authors Funded by the National Institutes of Health (NIH)

The editors of this journal are able to deposit papers to the NIH Manuscript Submission System (NIHMS, http://nihms.nih.gov/) on your behalf. If you are funded by NIH, please request this service from our editors after acceptance of your paper.

[Return to top]

Manuscript Preparation

General Considerations

  • Data Descriptors should comprise:
    • Front matter: Title, Author list, Affiliations, Abstract, Keywords
    • Dataset: title, DOI (or unique identifier), creator, publisher and location (e.g. URL) of the dataset
    • Dataset License
    • Research manuscript sections: Summary, Data Description, Methods, User notes
    • Back matter: Acknowledgments, Author Contributions, Conflicts of Interest, References.
  • Research manuscripts should comprise:
    • Front matter: Title, Author list, Affiliations, Abstract, Keywords
    • Research manuscript sections: Introduction, Results, Discussion, Materials and Methods, Conclusions (optional).
    • Back matter: Supplementary Materials, Acknowledgments, Author Contributions, Conflicts of Interest, References.
  • Review manuscripts should comprise the front matter, literature review sections and the back matter. The template file can also be used to prepare the front and back matter of your review manuscript. It is not necessary to follow the remaining structure. Structured reviews and meta-analyses should use the same structure as research articles and ensure they conform to the PRISMA guidelines.
  • Case reports should include a succinct introduction about the general medical condition or relevant symptoms that will be discussed in the case report; the case presentation including all of the relevant de-identified demographic and descriptive information about the patient(s), and a description of the symptoms, diagnosis, treatment, and outcome; a discussion providing context and any necessary explanation of specific treatment decisions; a conclusion briefly outlining the take-home message and the lessons learned.
  • Graphical Abstract:

A graphical abstract (GA) is an image that appears alongside the text abstract in the Table of Contents. In addition to summarizing the content, it should represent the topic of the article in an attention-grabbing way. Moreover, it should not be exactly the same as the Figure in the paper or just a simple superposition of several subfigures. Note that the GA must be original and unpublished artwork. Any postage stamps, currency from any country, or trademarked items should not be included in it.

The GA should be a high-quality illustration or diagram in any of the following formats: PNG, JPEG, TIFF, or SVG. Written text in a GA should be clear and easy to read, using one of the following fonts: Times, Arial, Courier, Helvetica, Ubuntu or Calibri.

The minimum required size for the GA is 560 × 1100 pixels (height × width). The size should be of high quality in order to reproduce well.

  • Acronyms/Abbreviations/Initialisms should be defined the first time they appear in each of three sections: the abstract; the main text; the first figure or table. When defined for the first time, the acronym/abbreviation/initialism should be added in parentheses after the written-out form.
  • SI Units (International System of Units) should be used. Imperial, US customary and other units should be converted to SI units whenever possible.
  • Accession numbers of RNA, DNA and protein sequences used in the manuscript should be provided in the Materials and Methods section. Also see the section on Deposition of Sequences and Expression Data.
  • Equations: If you are using Word, please use either the Microsoft Equation Editor or the MathType add-on. Equations should be editable by the editorial office and not appear in a picture format.
  • Research Data and supplementary materials: Note that publication of your manuscript implies that you must make all materials, data, and protocols associated with the publication available to readers. Disclose at the submission stage any restrictions on the availability of materials or information. Read the information about Supplementary Materials and Data Deposit for additional guidelines.
  • Preregistration: Where authors have preregistered studies or analysis plans, links to the preregistration must be provided in the manuscript.
  • Guidelines and standards: FUTURE  follows standards and guidelines for certain types of research. 

[Return to top]

Front Matter

These sections should appear in all manuscript types

  • Title: The title of your manuscript should be concise, specific and relevant. It should identify if the study reports (human or animal) trial data, or is a systematic review, meta-analysis or replication study. When gene or protein names are included, the abbreviated name rather than full name should be used. Please do not include abbreviated or short forms of the title, such as a running title or head. These will be removed by our Editorial Office.
  • Author List and Affiliations: Authors' full first and last names must be provided. The initials of any middle names can be added. The PubMed/MEDLINE standard format is used for affiliations: complete address information including city, zip code, state/province, and country. At least one author should be designated as the corresponding author, and their email address and other details included at the end of the affiliation section. After acceptance, updates to author names or affiliations may not be permitted. Equal Contributions: authors who have contributed equally should be marked with a superscript symbol (†). The symbol must be included below the affiliations, and the following statement added: “These authors contributed equally to this work”. The equal roles of authors should also be adequately disclosed in the author contributions statement. Please read the criteria to qualify for authorship.
  • Abstract: The abstract should be a total of about 200 words maximum. The abstract should be a single paragraph and should follow the style of structured abstracts, but without headings: 1) Background: Place the question addressed in a broad context and highlight the purpose of the study; 2) Methods: Describe briefly the main methods or treatments applied. Include any relevant preregistration numbers, and species and strains of any animals used. 3) Results: Summarize the article's main findings; and 4) Conclusion: Indicate the main conclusions or interpretations. The abstract should be an objective representation of the article: it must not contain results which are not presented and substantiated in the main text and should not exaggerate the main conclusions.
  • Keywords: Three to ten pertinent keywords need to be added after the abstract. We recommend that the keywords are specific to the article, yet reasonably common within the subject discipline.

Research Manuscript Sections

  • Introduction: The introduction should briefly place the study in a broad context and highlight why it is important. It should define the purpose of the work and its significance, including specific hypotheses being tested. The current state of the research field should be reviewed carefully and key publications cited. Please highlight controversial and diverging hypotheses when necessary. Finally, briefly mention the main aim of the work and highlight the main conclusions. Keep the introduction comprehensible to scientists working outside the topic of the paper.
  • Results: Provide a concise and precise description of the experimental results, their interpretation as well as the experimental conclusions that can be drawn.
  • Discussion: Authors should discuss the results and how they can be interpreted in perspective of previous studies and of the working hypotheses. The findings and their implications should be discussed in the broadest context possible and limitations of the work highlighted. Future research directions may also be mentioned. This section may be combined with Results.
  • Materials and Methods: They should be described with sufficient detail to allow others to replicate and build on published results. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited. Give the name and version of any software used and make clear whether computer code used is available. Include any pre-registration codes.
  • Conclusions: This section is not mandatory but can be added to the manuscript if the discussion is unusually long or complex.
  • Patents: This section is not mandatory but may be added if there are patents resulting from the work reported in this manuscript.

[Return to top]

Data Descriptor Information

For a Data Descriptor, the following additional information is required (see the template).

  • Dataset: DOI number or link to the deposited dataset in cases where the dataset held at a third party repository. If the dataset is submitted and will be published as a supplement, this field will be filled by the editors of the journal. In this case, the data should be uploaded at the time of submission.
  • Dataset License: License under which the dataset is made available (CC0 is recommended, but other licenses are permissible).

Data Descriptors comprise the following sections:

  • Summary: A short summary of the dataset, methods, background information on why and how the dataset was collected, short description of funded or unfunded research projects that are or will eventually be based on the dataset, and list of publications based on the dataset that were possibly already published. Optionally, authors may wish to describe potential benefits of publicly releasing and describing the dataset. In general, the Summary section is similar to an introduction section in a research article.
  • Data Description: What data is contained? Which format? How can it be read and interpreted? For example, in tabular data give a full description of each column heading.
  • Methods: Main methods applied to collect and treat, as well as to use and reuse the data. Notes on validation and curation techniques applied. Notes on data quality, noise, etc.
  • Usage notes (optional): Further notes on the usage of the dataset that will help other researchers to access and further understand practical aspects of working with the data. If there are ethical or compelling commercial reasons that the data cannot be made available, either in part or in full, these should be described in as much detail as possible. You should make clear how the data can be accessed and if there are circumstances in which access would be denied (e.g. if complying with the request would compromise anonymity of human participants or if an embargo applies); we recommend full access wherever possible.

[Return to top]

Back Matter

  • Supplementary Materials: Describe any supplementary material published online alongside the manuscript (figure, tables, video, spreadsheets, etc.). Please indicate the name and title of each element as follows Figure S1: title, Table S1: title, etc.
  • Funding: All sources of funding of the study should be disclosed. Clearly indicate grants that you have received in support of your research work and if you received funds to cover publication costs. Note that some funders will not refund article processing charges (APC) if the funder and grant number are not clearly and correctly identified in the paper. Funding information can be entered separately into the submission system by the authors during submission of their manuscript. Such funding information, if available, will be deposited to FundRef if the manuscript is finally published.
    Please add: “This research received no external funding” or “This research was funded by [name of funder] grant number [xxx]” and “The APC was funded by [XXX]” in this section. Check carefully that the details given are accurate and use the standard spelling of funding agency names at https://search.crossref.org/funding, any errors may affect your future funding.
  • Acknowledgments: In this section you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).
  • Author Contributions: Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it; AND has approved the submitted version (and version substantially edited by journal staff that involves the author’s contribution to the study); AND agrees to be personally accountable for the author’s own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature.
    For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.”, please turn to the CRediT taxonomy for the term explanation. For more background on CRediT, see here. "Authorship must include and be limited to those who have contributed substantially to the work. Please read the section concerning the criteria to qualify for authorship carefully".
  • Data Availability Statement: In this section, please provide details regarding where data supporting reported results can be found, including links to publicly archived datasets analyzed or generated during the study. Please refer to suggested Data Availability Statements in section “FUTURE  Research Data Policies”. You might choose to exclude this statement if the study did not report any data.
  • Conflicts of Interest: Authors must identify and declare any personal circumstances or interest that may be perceived as influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state "The authors declare no conflict of interest." Any role of the funding sponsors in the choice of research project; design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results must be declared in this section. Data does not publish studies funded partially or fully by the tobacco industry. Any projects funded by industry must pay special attention to the full declaration of funder involvement. If there is no role, please state “The sponsors had no role in the design, execution, interpretation, or writing of the study”. For more details please see Conflict of Interest.
  • References: References must be numbered in order of appearance in the text (including table captions and figure legends) and listed individually at the end of the manuscript. We recommend preparing the references with a bibliography software package, such as EndNoteReferenceManager or Zotero to avoid typing mistakes and duplicated references. We encourage citations to data, computer code and other citable research material. If available online, you may use reference style 9. below.
  • Citations and References in Supplementary files are permitted provided that they also appear in the main text and in the reference list.

In the text, reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example [1], [1–3] or [1,3]. For embedded citations in the text with pagination, use both parentheses and brackets to indicate the reference number and page numbers; for example [5] (p. 10). or [6] (pp. 101–105).

The reference list should include the full title, as recommended by the ACS style guide. Style files for Endnote and Zotero are available.

References should be described as follows, depending on the type of work:

  • Journal Articles:
    1. Author 1, A.B.; Author 2, C.D. Title of the article. Abbreviated Journal NameYearVolume, page range.
  • Books and Book Chapters:
    2. Author 1, A.; Author 2, B. Book Title, 3rd ed.; Publisher: Publisher Location, Country, Year; pp. 154–196.
    3. Author 1, A.; Author 2, B. Title of the chapter. In Book Title, 2nd ed.; Editor 1, A., Editor 2, B., Eds.; Publisher: Publisher Location, Country, Year; Volume 3, pp. 154–196.
  • Unpublished materials intended for publication:
    4. Author 1, A.B.; Author 2, C. Title of Unpublished Work (optional). Correspondence Affiliation, City, State, Country. year, status(manuscript in preparationto be submitted).
    5. Author 1, A.B.; Author 2, C. Title of Unpublished Work. Abbreviated Journal Name year, phrase indicating stage of publication (submittedacceptedin press).
  • Unpublished materials not intended for publication:
    6. Author 1, A.B. (Affiliation, City, State, Country); Author 2, C. (Affiliation, City, State, Country). Phase describing the material, year. (phase: Personal communication; Private communication; Unpublished work; etc.)
  • Conference Proceedings:
    7. Author 1, A.B.; Author 2, C.D.; Author 3, E.F. Title of Presentation. In Title of the Collected Work(if available), Proceedings of the Name of the Conference, Location of Conference, Country, Date of Conference; Editor 1, Editor 2, Eds. (if available); Publisher: City, Country, Year (if available); Abstract Number (optional), Pagination (optional).
  • Thesis:
    8. Author 1, A.B. Title of Thesis. Level of Thesis, Degree-Granting University, Location of University, Date of Completion.
  • Websites:
    9. Title of Site. Available online: URL (accessed on Day Month Year).
    Unlike published works, websites may change over time or disappear, so we encourage you create an archive of the cited website using a service such as WebCite. Archived websites should be cited using the link provided as follows:
    10. Title of Site. URL (archived on Day Month Year).
    See the Reference List and Citations Guidefor more detailed information.

[Return to top]

Preparing Figures, Schemes and Tables

  • File for Figures and Schemes must be provided during submission in a single zip archive and at a sufficiently high resolution (minimum 1000 pixels width/height, or a resolution of 300 dpi or higher). Common formats are accepted, however, TIFF, JPEG, EPS and PDF are preferred.
  • Data can publish multimedia files in articles or as supplementary materials. Please contact the editorial office for further information.
  • All Figures, Schemes and Tables should be inserted into the main text close to their first citation and must be numbered following their number of appearance (Figure 1, Scheme I, Figure 2, Scheme II, Table 1, etc.).
  • All Figures, Schemes and Tables should have a short explanatory title and caption.
  • All table columns should have an explanatory heading. To facilitate the copy-editing of larger tables, smaller fonts may be used, but no less than 8 pt. in size. Authors should use the Table option of Microsoft Word to create tables.
  • Authors are encouraged to prepare figures and schemes in color (RGB at 8-bit per channel). There is no additional cost for publishing full color graphics.

[Return to top]

Original Images for Blots and Gels Requirements

For the main text, please ensure that:

  • All experimental samples and controls used for one comparative analysis are run on the same blot/gel.
  • Image processing methods, such as adjusting the brightness or contrast, do not alter or distort the information in the figure and are applied to every pixel. High-contrast blots/gels are discouraged.
  • Cropped blots/gels present in the main text retain all important information and bands.
  • You have checked figures for duplications and ensured the figure legends are clear and accurate. Please include all relevant information in the figure legends and clearly indicate any re-arrangement of lanes.

In order to ensure the integrity and scientific validity of blots (including, but not limited to, Western blots) and the reporting of gel data, original, uncropped and unadjusted images should be uploaded as Supporting Information files at the time of initial submission.

A single PDF file or a zip folder including all the original images reported in the main figure and supplemental figures should be prepared. Authors should annotate each original image, corresponding to the figure in the main article or supplementary materials, and label each lane or loading order. All experimental samples and controls used for one comparative analysis should be run on the same blot/gel image. For quantitative analyses, please provide the blots/gels for each independent biological replicate used in the analysis.

[Return to top]

Supplementary Materials, Data Deposit and Software Source Code

FUTURE  Research Data Policies

FUTURE  is committed to supporting open scientific exchange and enabling our authors to achieve best practices in sharing and archiving research data. We encourage all authors of articles published in FUTURE  journals to share their research data. Individual journal guidelines can be found at the journal ‘Instructions for Authors’ page. Data sharing policies concern the minimal dataset that supports the central findings of a published study. Generated data should be publicly available and cited in accordance with journal guidelines.

FUTURE  data policies are informed by TOP Guidelines and FAIR Principles.

Where ethical, legal or privacy issues are present, data should not be shared. The authors should make any limitations clear in the Data Availability Statement upon submission. Authors should ensure that data shared are in accordance with consent provided by participants on the use of confidential data.

Data Availability Statements provide details regarding where data supporting reported results can be found, including links to publicly archived datasets analyzed or generated during the study.

Below are suggested Data Availability Statements:

  • Data available in a publicly accessible repository
    The data presented in this study are openly available in [repository name e.g., FigShare] at [doi], reference number [reference number].
  • Data available in a publicly accessible repository that does not issue DOIs
    Publicly available datasets were analyzed in this study. This data can be found here: [link/accession number]
  • Data available on request due to restrictions eg privacy or ethical
    The data presented in this study are available on request from the corresponding author. The data are not publicly available due to [insert reason here]
  • 3rd Party Data
    Restrictions apply to the availability of these data. Data was obtained from [third party] and are available [from the authors / at URL] with the permission of [third party].
  • Data sharing not applicable
    No new data were created or analyzed in this study. Data sharing is not applicable to this article.
  • Data is contained within the article or supplementary material
    The data presented in this study are available in [insert article or supplementary material here]

Data citation:

  • [dataset] Authors. Year. Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g., DOI).

Computer Code and Software

For work where novel computer code was developed, authors should release the code either by depositing in a recognized, public repository such as GitHub or uploading as supplementary information to the publication. The name, version, corporation and location information for all software used should be clearly indicated. Please include all the parameters used to run software/programs analyses.

Supplementary Material

Additional data and files can be uploaded as "Supplementary Files" during the manuscript submission process. The supplementary files will also be available to the referees as part of the peer-review process. Any file format is acceptable; however, we recommend that common, non-proprietary formats are used where possible. For more information on supplementary materials, please refer to https://www.FUTURE .com/authors/layout#_bookmark83.

References in Supplementary Files

Citations and References in Supplementary files are permitted provided that they also appear in the reference list of the main text.

Unpublished Data

Restrictions on data availability should be noted during submission and in the manuscript. "Data not shown" should be avoided: authors are encouraged to publish all observations related to the submitted manuscript as Supplementary Material. "Unpublished data" intended for publication in a manuscript that is either planned, "in preparation" or "submitted" but not yet accepted, should be cited in the text and a reference should be added in the References section. "Personal Communication" should also be cited in the text and reference added in the References section. (see also the FUTURE  reference list and citations style guide).

Remote Hosting and Large Data Sets

Data may be deposited with specialized service providers or institutional/subject repositories, preferably those that use the DataCite mechanism. Large data sets and files greater than 60 MB must be deposited in this way. For a list of other repositories specialized in scientific and experimental data, please consult databib.org or re3data.org. The data repository name, link to the data set (URL) and accession number, doi or handle number of the data set must be provided in the paper. The journal Data also accepts submissions of data set papers.

Deposition of Sequences and Expression Data

New sequence information must be deposited to the appropriate database prior to submission of the manuscript. Accession numbers provided by the database should be included in the submitted manuscript. Manuscripts will not be published until the accession number is provided.

  • New nucleic acid sequences must be deposited into an acceptable repository such as GenBankEMBL, or DDBJ. Sequences should be submitted to only one database.
  • New high throughput sequencing (HTS) datasets (RNA-seq, ChIP-Seq, degradome analysis, …) must be deposited either in the GEO database or in the NCBI’s Sequence Read Archive (SRA).
  • New microarray data must be deposited either in the GEO or the ArrayExpress databases.The "Minimal Information About a Microarray Experiment" (MIAME) guidelines published by the Microarray Gene Expression Data Society must be followed.
  • New protein sequences obtained by protein sequencing must be submitted to UniProt (submission tool SPIN). Annotated protein structure and its reference sequence must be submitted to RCSB of Protein Data Bank.

All sequence names and the accession numbers provided by the databases must be provided in the Materials and Methods section of the article.

Deposition of Proteomics Data

Methods used to generate the proteomics data should be described in detail and we encourage authors to adhere to the "Minimum Information About a Proteomics Experiment". All generated mass spectrometry raw data must be deposited in the appropriate public database such as ProteomeXchangePRIDE or jPOST. At the time of submission, please include all relevant information in the materials and methods section, such as repository where the data was submitted and link, data set identifier, username and password needed to access the data.

[Return to top]


Copyright and Permissions


By submitting a manuscript to the editor or publisher you are deemed to have granted permission to publish the manuscript.


Publication Process and Timeline

Future journals follow these general steps in moving your submission from manuscript to typeset PDF. However, there are exceptions. Contact your Production Editor if you have any questions about the production process.

Please note that we consider the version of the manuscript that you submitted to be the only and official version of your manuscript in production. If you have changes to make from this point on, please make them only to an in-production manuscript that you receive from your Production Editor.

Evaluated by a Technical Reviewer

Following its arrival at Annual Reviews, your manuscript is processed, evaluated by a technical reviewer, and copyedited. Although articles are invited, a manuscript may be rejected as unsuitable for publication if it does not meet the general guidelines for an article or if it is not of high enough quality as determined by the editors.

Galley Proofs

Once the technical editor has approved the manuscript for publication and the manuscript has been copyedited by a Future Journals Production Editor or freelance copyeditor, you will receive electronic galley proofs. If your original submission was in Microsoft Word, these galley proofs will also be in Microsoft Word with the reviewer’s comments and copyeditor’s changes and queries marked with Word’s tracking function. A PDF will be sent to authors using LaTeX. (Note that if major revisions are requested, the Production Editor will contact you prior to copyediting.)


Future Journals endeavors to send you your copyedited galley proofs within 6 weeks of submission, but this timeline depends on several factors. Contact your Production Editor  if you have questions about timing and schedules.

If you anticipate being unavailable at any time during the production process, please contact your Production Editor, as many stages are time-sensitive.

Revisions Permitted at the Galley Stage

The galley stage is your final opportunity to make stylistic changes to your review. Because of time and cost constraints, once we have sent your manuscript to the compositor to be typeset (the “page proof” stage, discussed below), stylistic changes are not permitted. Please use this galley proof to your advantage and make any insertions/deletions you deem necessary. However, manuscripts should not be extensively rewritten at this stage.

Retain All Tracked Changes

If you receive your galley proofs in Microsoft Word, please do not “accept” or “reject” the tracked changes from the copyeditor. If you do not agree with an editorial change, simply type “NO,” and we will undo the change. Corrections and revisions must be indicated using Word’s tracking feature. All tracks will be “cleaned up” by the Production Editor after you return the manuscript.


During the production process, you will be contacted by a Future Journal  Illustration Editor regarding edits to your figures. Contact your Production Editor if you have questions about revisions to your figures or for the contact information of your Illustration Editor. You may also refer to the Author Graphics Guide in the Author Resource Center.

Page Proofs

Typeset page proofs are sent electronically approximately one month after you return the corrected galley proofs and approve the final figures. With the author’s permission, these typeset page proofs, not yet incorporating any final corrections, may be published online ahead of print (a “Review in Advance”—see next section). Final corrections are incorporated before final online/print publication.

At the page proof (PDF) stage, only typos, typesetter’s errors, or factual errors may be corrected, and “In press” references may be updated. Any changes that affect the layout of the review cannot be made.

Reviews in Advance

You have the option to have the uncorrected typeset page proof posted online approximately one week after it is available (your Production Editor will send you a form to accept or reject this option). This Review in Advance (RIA) is then replaced by the final version of the article when the complete volume is published online.


The title and abstract of your article will be available on the Future Journals website about seven months before final publication. With prompt submission and your approval, the typeset page proof of your article, lacking any final corrections, will be published online as an RIA. The final full text will replace the RIA upon final publication. For journals with a print version, the hard copy publishes approximately one month after final online publication.


Annual Review authors can provide author ePrints to colleagues who request them. An author ePrint is a keyed URL (a unique Web address) that grants free online access to the author’s review in both Web-browsable form (as HTML pages, with links to other online resources) and “reprint” form (a locally printable PDF file). Your Production Editor will provide that information when the final volume is published online. More information about self-archiving and permissions is on our website.